The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPO.L Regulatory News (SPO)

  • There is currently no data for SPO

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 (DD) - Contagious Gaming Inc.

24 Aug 2015 15:19

RNS Number : 9117W
Dundee Securities Europe LLP
24 August 2015
 

FORM 8 (DD)

 

PUBLIC DEALING DISCLOSURE BY A PARTY TO AN OFFER OR PERSON ACTING IN CONCERT (INCLUDING DEALINGS FOR THE ACCOUNT OF DISCRETIONARY INVESTMENT CLIENTS)

Rules 8.1, 8.2 and 8.4 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Dundee Securities Europe LLP

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

Dundee Securities Limited

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Contagious Gaming Inc.

(d) Status of person making the disclosure:

e.g. offeror, offeree, person acting in concert with the offeror/offeree (specify name of offeror/offeree)

Offeror concert party member

(e) Date dealing undertaken:

20th August 2015

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

YES / NO / N/A

If YES, specify which:

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing

 

Class of relevant security:

 

Common shares

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

0

0.0

(2) Cash-settled derivatives:

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

TOTAL:

0

0.00

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

3. DEALINGS BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

(i) Party to an offer or person acting in concert (except for a principal trader in the same group as a connected adviser)

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

Common

Purchase

31,000

C$ 0.2800

Common

Purchase

29,000

C$ 0.2700

Common

Purchase

7,500

C$ 0.2600

Common

Sale

67,500

C$ 0.2735

 

(ii) Principal trader where the sole reason for the connection is that the principal trader is in the same group as a connected adviser

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

 

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer or person acting in concert making the disclosure and any other person:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer or person acting in concert making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

YES/NO

Supplemental Form 8 (SBL)

YES/NO

 

 

Date of disclosure:

24th August 2015

Contact name:

Mike Dack

Telephone number:

020 3440 6860

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DCCSEMFLLFISEFA
Date   Source Headline
17th Oct 20237:00 amRNSCancellation - Sportech PLC
16th Oct 20237:00 amRNSMatched Bargain Dealing Facility
13th Oct 20233:31 pmRNSHolding(s) in Company
12th Oct 20235:45 pmRNSSportech
9th Oct 20232:17 pmRNSHolding(s) in Company
5th Oct 202310:00 amRNSResult of General Meeting
28th Sep 202311:50 amRNSDirector/PDMR Shareholding
28th Sep 202310:03 amRNSHolding(s) in Company
28th Sep 20239:55 amRNSHolding(s) in Company
27th Sep 20234:00 pmRNSDirector/PDMR Shareholding
25th Sep 202312:21 pmRNSDirector/PDMR Shareholding
25th Sep 20237:00 amRNSHolding(s) in Company
19th Sep 20237:00 amRNSPublication of Circular and Notice of GM
14th Sep 20237:00 amRNSNotification of Major Holdings
11th Sep 20237:01 amRNSProposed De-lisiting
11th Sep 20237:00 amRNSHalf-year Report
30th Aug 20232:02 pmRNSNotification of Major Holdings
27th Jul 20231:35 pmRNSCapital distribution dates
24th Jul 20235:25 pmRNSTotal Voting Rights and Distribution
19th Jul 202312:00 pmRNSResult of Meeting
28th Jun 20237:00 amRNSPosting of Circular, Notice of GM and Distribution
26th Jun 20237:00 amRNSShare Restructure, Distribution and GM
30th May 20235:48 pmRNSResult of AGM
30th May 20237:00 amRNSAGM Trading Update
5th May 20237:00 amRNSNotice of AGM
18th Apr 20237:00 amRNSFinal Results
28th Feb 20233:34 pmRNSNotification of Major Holdings
24th Jan 20237:35 amRNSFY 2022 pre-close update
4th Jan 20234:13 pmRNSNotification of Major Holdings
24th Oct 20228:30 amRNSDirector/PDMR Shareholding
17th Oct 20227:00 amRNSNotification of Major Holings
17th Oct 20227:00 amRNSNotification of Major Holdings
14th Oct 20229:44 amRNSNotification of Major Holdings
14th Oct 20227:00 amRNSDirector/PDMR Shareholding
11th Oct 20224:41 pmRNSSecond Price Monitoring Extn
11th Oct 20224:35 pmRNSPrice Monitoring Extension
1st Sep 20227:00 amRNSInterim Results
24th Aug 20227:00 amRNSDirectorate Change
28th Jul 20227:00 amRNSDirectorate Change
31st May 20222:00 pmRNSResult of Annual General Meeting
31st May 20227:00 amRNSAGM Trading Update and Board Changes
25th May 20227:00 amRNSDirectorate Change
6th May 20227:00 amRNSNotice of Annual General Meeting
27th Apr 20227:00 amRNSStatement re Capital Distribution to Shareholders
14th Apr 20227:00 amRNSDirectorate Change
1st Apr 20227:00 amRNSDirectorate Changes
31st Mar 20227:00 amRNSFinal Results
22nd Mar 20221:42 pmRNSNotification of Major Holdings
22nd Mar 202211:09 amRNSNotification of Major Holdings
15th Mar 20224:46 pmRNSNotification of Major Holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.